Trial Search Results

Re-Energize Fontan

Survival of children with single ventricles ("half a heart") beyond the neonatal period has increased dramatically with the staged Fontan palliation. Yet, long-term morbidity remains high. By the age of 40, 50% of Fontan patients will have died or undergone heart transplantation. With >1,000 Fontan palliations performed in the US annually, there is a burgeoning population of Fontan patients at risk for progressive heart failure and death. Factors that contribute to onset and progression of heart failure in Fontan patients remain incompletely understood. However, it is established that Fontan patients have poor exercise capacity, associated with a greater risk of morbidity and mortality, in addition to decreased muscle mass, abnormal muscle function, and endothelial dysfunction contributing to disease progression. In adult patients with two ventricles and heart failure, reduced exercise capacity, muscle mass, and muscle strength are powerful predictors of poor outcomes, and exercise interventions can not only improve exercise capacity and muscle mass, but also reverse endothelial dysfunction. Limited exercise interventions in children with congenital heart disease have demonstrated that exercise is safe and effective; however, these studies have been conducted in small, heterogeneous groups, and most had few Fontan patients. Furthermore, none of these interventions have studied the impact of exercise on muscle mass or mitochondrial function, or endothelial function. The investigators propose a milestone-driven, randomized controlled trial in pediatric Fontan patients to test the hypothesis that a live-video-supervised exercise (aerobic + resistance) intervention will improve cardiac and physical capacity; muscle mass, strength and function; and endothelial function. The investigators' ultimate goal is the translation of this model to clinical application as an "exercise prescription" to intervene early in pediatric Fontan patients and decrease long-term morbidity and mortality.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: The Methodist Hospital Research Institute

Stanford Investigator(s):

Intervention(s):

  • Other: Live-Video-Supervised Exercise Intervention
  • Other: Usual Care then Live-Video Supervised Exercise Intervention

Phase:

N/A

Eligibility


Inclusion Criteria:

   - 9-19 years of age

   - Fontan palliation

   - Ability to fast overnight

   - Cardiac clearance to exercise by primary cardiologist

   - Presence of an adult at home during exercise sessions for patients <14 years old

   - English-speaking patient.

Exclusion Criteria:

   - NYHA Class IV (severe heart failure)

   - Acute illness within the past three months

   - Active protein losing enteropathy (albumin <2.5 mg/dL)

   - Implanted pacemaker

   - Cognitive delay deemed severe enough to inhibit the ability to follow the exercise

Ages Eligible for Study

9 Years - 19 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Seda Tierney, MD
650-736-7747
Recruiting